Journal: Frontiers in Immunology
Article Title: Lyl1-deficiency promotes inflammatory responses and increases mycobacterial burden in response to Mycobacterium tuberculosis infection in mice
doi: 10.3389/fimmu.2022.948047
Figure Lengend Snippet: Lyl1-deletion enhances lung neutrophil and monocyte recruitment in response to chronic hypervirulent Mtb infection in vivo . (A-C) Littermate control (WT) and Lyl1 -/- mice were infected with ~100 CFU/mouse intranasally with Mtb HN878 (n = 5 mice/group) and sacrificed at either 6- or 10-weeks post infection. Using flow cytometry, single cell suspension of lung tissue was analyzed for (A, B) lymphoid and (C) myeloid total cell numbers and percentages of live cells. Naïve, central memory and effector/effector memory percentages are presented as ratio in the parent CD4 or CD8 population. Surface markers of the different cell populations are as follows (according to the gating strategy Figures S5-10): gamma delta T-cells (gd T) = CD3 + gdTCR + ; NK cells = NK1.1 + CD3 - ; B-cells = CD19 + CD3 - ; T-cells = CD3 + CD19 - ; CD4 + T-cells = CD3 + CD4 + ; CD8 + T-cells = CD3 + CD8 +; Neutrophils (Neut.) = Ly6G + CD11b + ; Eosinophils (Eosin.) = SiglecF + CD11b + CD64 - ; CD11b + DC = CD11c + MHCII + CD11b + CD64 - ; CD103 + DC = CD11c + MHCII + CD103 + CD64 - ; Alveolar Macrophages (Alv. Macs) = CD64 + MerTK + SiglecF + CD11c + ; Interstitial Macrophages (Int. Macs) = CD64 + MerTK + SiglecF - CD11b + CD11c - ; Monocytes (Mono) = Ly6C + CD11b + CD64 - ; Monocyte-derived DC (MoDC) = CD64 + CD11b + CD11c + . Line denotes Mean. Data shown is representative of 2-3 independent experiments. Unpaired student t-test analysis at *p < 0.05, **p < 0.01 to determine significance.
Article Snippet: A single-cell suspension (1x10 6 cells) from indicated organs were stained for the following surface markers suspended in PBS supplemented with 1% BSA and 0.1% NaN 3 , purchased from either BD Biosciences (Franklin Lakes, New Jersey), BioLegend (San Diego, California) or eBioScience (San Diego, California): PD-1 (Clone 29F.1A12 FITC, Biolegend); CD4 (Clone RM4-5 BV510, BD Biosciences); CD44 (Clone IM7 PE, BD Biosciences); NK1.1 (Clone PK136 APC-Cy7, BD Biosciences); CD3 (Clone 500A2 AF700, BD Biosciences); CXCR5 (Clone 2G8 PE-Cy7, BD Biosciences); CD62L (Clone MEL-14 V450, BD Biosciences); CD19 (Clone 1D3 PerCPCy5.5, BD Biosciences); CD8 (Clone 53-6.7 APC, BD Biosciences); KLRG1 (Clone 2F1/KLRG1 BV785, Biolegend); CD64 (Clone X54-5/7 PeCy7, BioLegend); Ly6C (Clone AL-21 PerCPCy5.5, BD Biosciences); CD11b (Clone M1/70 V450, BD Biosciences); MHC II (Clone M5/114.15.2 AF700, BioLegend); CD11c (Clone HL3 APC, BD Biosciences); SiglecF (Clone E5-2440 APC-Cy7, BD Biosciences); Ly6G (Clone 1A8 FITC, BD Biosciences); MerTK (Clone 108928 BV786, BD Biosciences); CD103 (Clone M290 PE, BD Biosciences); F4/80 (Clone BM8 PeCy7, eBioscience); CD169 (Clone SER-4 APC-eFluor780, eBioscience).
Techniques: Infection, In Vivo, Control, Flow Cytometry, Suspension, Derivative Assay